Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mio, Nakagawa"'
Publikováno v:
Journal of Physical Fitness and Sports Medicine, Vol 4, Iss 3, Pp 287-294 (2015)
Sarcopenia from aging, inactivity, weightlessness, disease and malnutrition causes social problems due to associated physical dysfunction, a decrease in QOL, and risk of death. As a means of alleviating sarcopenia, appropriate exercise and nutrition
Externí odkaz:
https://doaj.org/article/46cab9fbfa39433b8dc38f190dd68d3d
Autor:
Kimihiko Ito, Mio Nakagawa, Mototsugu Shimokawa, Kensuke Hori, Lena Tashima, Mayako Goto, Satoshi Yanagida, Jiro Suzuki, Ryusuke Kaya, Ayako Kawabata, Kyosuke Yamada, Jongmyung Park, Hiroki Nasu, Shin Nishio, Eiji Kondo, Michiko Kaneda, Hiroshi Tsubamoto, Atsushi Arakawa, Takayuki Nagasawa, Takashi Motohashi
Publikováno v:
Anti-Cancer Drugs; Aug2023, Vol. 34 Issue 7, p857-865, 9p
Autor:
Yayoi Fukuda, Ayuko Otoshi, Chikako Tsukahara, Yukihiro Nishio, Takashi Miyatake, Tomomi Egawa-Takata, Yoshimi Tokugawa, Mio Nakagawa, Yuri Kamino
Publikováno v:
International Journal of Surgery Case Reports
Highlights • There are few reports about laparoscopic surgery involving patients with LP shunts. • This is the first report about laparoscopic gynecological surgery with an LP shunt. • In gynecological operations, the head of the shunt tube can
Autor:
Tomomi Egawa-Takata, Mio Nakagawa, Chikako Tsukahara, Takashi Miyatake, Yukihiro Nishio, Yuri Kamino
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 35:279-282
Autor:
Mio, Nakagawa, Kimihiko, Ito, Kiri, Uragami, Junko, Suzuki, Mayu, Shiomi, Hitomi, Ono, Kanoko, Shimoji, Michiko, Yamashita, Masayo, Onoue, Emi, Yoshioka, Mayako, Goto, Lena, Tashima, Kensuke, Hori
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(3)
Ovarian clear cell carcinoma(OCCC)shows a poor response to standard chemotherapy, and it is often difficult to choose a regimen for patients with recurrent OCCC. Several reports have suggested a synergistic effect between gemcitabine and cisplatin; a
Autor:
Rieko Okubo, Mio Nakagawa, Hiromasa Kuroda, Kensuke Hori, Tomohiko Tsuruta, Taro Yagi, Lena Tashima, Kimihiko Ito
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 34:252-256
Autor:
Kanoko, Shimoji, Kimihiko, Ito, Lena, Tashima, Tomohiko, Tsuruta, Mio, Nakagawa, Yoshinori, Kagawa, Yutaka, Takeda, Takashi, Iwata, Taro, Yagi, Chihiro, Odani, Hitomi, Ono, Rieko, Okubo, Mayako, Goto, Kensuke, Hori
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 44(8)
The current standard treatment for advanced ovarian cancer is primary debulking surgery(PDS). We may expect a good prognosis if complete debulking(no visible residual tumor)is possible. However, if complete surgery is not possible owing to the locati
Autor:
Rieko, Okubo, Kimihiko, Ito, Shinichi, Nakatsuka, Hitoshi, Watanabe, Taro, Yagi, Chihiro, Odani, Hitomi, Ono, Kanoko, Shimoji, Mio, Nakagawa, Mayako, Goto, Tomohiko, Tsuruta, Kensuke, Hori, Lena, Tashima
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 44(8)
The incidence of lymph node metastasis in pT1 epithelial ovarian cancer is between 5% and 21%. Most cases with lymph node metastasis are those of serous carcinoma; it is relatively rare in mucinous carcinoma. Therefore, there is a recent trend to omi
Autor:
Kensuke, Hori, Tomohiko, Tsuruta, Chihiro, Odani, Hitomi, Ono, Rieko, Ohkubo, Kanoko, Shimoji, Junko, Murakami, Mio, Nakagawa, Lina, Tashima, Kimihiko, Ito
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 43(10)
Treatment for ovarian cancer with bevacizumab(Bmab)has been covered by public medical insurance in Japan since November 2013. It is recommended that the use of Bmab is limited to the first treatment for FIGO stage III or IV ovarian cancer. The OCEAN
Autor:
Junko, Murakami, Kensuke, Hori, Rieko, Okubo, Kanoko, Miyagi, Mayu, Shiomi, Kiri, Uragami, Mio, Nakagawa, Emi, Yoshioka, Tomohiko, Tsuruta, Rina, Tashima, Kimihiko, Ito
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 43(2)
We encountered a case of uterine leiomyosarcoma with multiple lung metastases. The patient was a 52-year-old woman who underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy followed by chemotherapy with gemcitabine and docetaxel.